Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.

Anticancer research - 1 Dec 2024

Shin Hyeran, Kim Yonghyo, Lee Yehyeong, Kim Jisoo, Ryu Yeong Chan, Kang Dong-Woo, Kim Tae Il, Cho Yong-Hee

Abstract excerpt

BACKGROUND/AIM: Desmoid tumors (DTs), or aggressive fibromatosis, are rare neoplasms arising from connective tissue, frequently exhibiting local invasiveness. The limited treatment options and high recurrence rates of DTs highlight the need for novel therapeutic strategies. This study investigated the efficacy of chlorhexidine dihydrochloride (CD) in inhibiting the growth of DTs and colorectal cancer (CRC)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli Protein
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Cell Survival

Share to Colorectal Neoplasms

Share to Desmoid Tumors

Share to HCT116 Cells

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 39626930
DOI: 10.21873/anticanres.17369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.PMID 39626930Read ↗

Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.Semantic proximity Read ↗

A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.Semantic proximity Read ↗

Evaluation of diagnostic algorithm and therapeutic interventions for intra-abdominal desmoid tumors.Semantic proximity Read ↗

Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor.Semantic proximity Read ↗

Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.Semantic proximity Read ↗

Desmoid tumor: a disease opportune for molecular insights.Semantic proximity Read ↗

Efficacy of auranofin as an inhibitor of desmoid progression.Semantic proximity Read ↗

Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis.Semantic proximity Read ↗

Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature ReviewSemantic proximity Read ↗

Characteristics of cultured desmoid cells with different CTNNB1 mutation status.Semantic proximity Read ↗

The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).Semantic proximity Read ↗

Optimal therapy for desmoid tumors: current options and challenges for the future.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.